These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6353463)

  • 1. The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment.
    Watt DC; Katz K; Shepherd M
    Psychol Med; 1983 Aug; 13(3):663-70. PubMed ID: 6353463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics.
    Shepherd M; Watt D; Falloon I; Smeeton N
    Psychol Med Monogr Suppl; 1989; 15():1-46. PubMed ID: 2798648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia [proceedings].
    Abuzzahab FS
    Psychopharmacol Bull; 1977 Jan; 13(1):71-3. PubMed ID: 319477
    [No Abstract]   [Full Text] [Related]  

  • 4. Pimozide versus fluphenazine in ambulatory schizophrenics: A 12-month comparison study.
    Donlon PT; Swaback DO; Osborne ML
    Dis Nerv Syst; 1977 Feb; 38(2):119-23. PubMed ID: 319967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.
    Barnes TR; Milavic G; Curson DA; Platt SD
    Soc Psychiatry; 1983; 18(4):193-9. PubMed ID: 6356386
    [No Abstract]   [Full Text] [Related]  

  • 6. The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 May; 8(2):265-74. PubMed ID: 418431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pimozide and the social behavior of schizophrenics.
    Lapierre YD; Lavallee J
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):181-88. PubMed ID: 809233
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity in chronic schizophrenic patients: comparison of pimozide with fluphenazine in a double blind trial.
    Sims AC; Burnside IG
    Psychol Med; 1975 May; 5(2):161-4. PubMed ID: 1099598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia.
    Abuzzahab FS; Zimmermann RL
    Psychopharmacol Bull; 1976 Apr; 12(2):26-7. PubMed ID: 769023
    [No Abstract]   [Full Text] [Related]  

  • 10. Low dose medication strategies in the maintenance treatment of schizophrenia.
    Kane JM
    Schizophr Bull; 1983; 9(4):528-32. PubMed ID: 6140751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group.
    McCreadie RG; Wiles D; Grant S; Crockett GT; Mahmood Z; Livingston MG; Watt JA; Greene JG; Kershaw PW; Todd NA
    Acta Psychiatr Scand; 1989 Dec; 80(6):597-602. PubMed ID: 2694767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dysphoric syndrome in schizophrenia and its implications for relapse.
    Hirsch SR; Jolley AG
    Br J Psychiatry Suppl; 1989 Jul; (5):46-50. PubMed ID: 2690890
    [No Abstract]   [Full Text] [Related]  

  • 13. Relapse rate and low serum neuroleptic levels in schizophrenics treated with fluphenazine: another view.
    Boza RA; Milanes F; Starkey T; Slater V; Dominguez F
    J Clin Psychiatry; 1988 Jun; 49(6):245. PubMed ID: 2897960
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G; Annable L; Ross-Chouinard A
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 Feb; 8(1):59-70. PubMed ID: 345313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie R; Mackie M; Morrison D; Kidd J
    Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled study of the antipsychotic and sedative effects of neuroleptic drugs and amphetamine in chronic schizophrenics. A clinical and experimental-psychological study.
    Cesarec Z; Eberhard G; Nordgren L
    Acta Psychiatr Scand Suppl; 1974; 249():65-77. PubMed ID: 4608707
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
    Abuzzahab FS; Zimmermann RL
    Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675
    [No Abstract]   [Full Text] [Related]  

  • 20. Pimozide in the maintenance treatment of apathetic and emotionally withdrawn schizophrenics.
    Cheadle AJ; Freeman HL
    Curr Med Res Opin; 1979; 6(1):35-43. PubMed ID: 378556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.